Pure Biologics S.A. Logo

Pure Biologics S.A.

ISIN: PLPRBLG00010 | Ticker: PUR | LEI: 2594002TXS19AUYHIF82

About Pure Biologics S.A.

Company Description

Pure Biologics is a biopharmaceutical company focused on the biological drug and non-systemic therapies discovery and development. We operate in the areas of immuno-oncology, autoimmunology, and rare neurological diseases, conducting research based on our own technology platforms for the selection of active molecules – antibodies and aptamers.

Pure Biologics also offers commercial partnership options in several areas including early phase biological drug discovery and development, selection and characterization of antibodies and aptamers, as well as protein production, purification and analysis.

Year founded


Served area



Duńska 11, 54-427 Wrocław – Poland

Filings & Publications

Shareholder information

Shares outstanding



Dec. 1, 2018

Stock exchange(s)

Warsaw Stock Exchange



Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.